Photobiomodulation therapy is largely characterized as a safe therapeutic model that can modulate the activity of inflammatory and immune biomarkers while facilitating a metabolic response that can regenerate damaged tissue.

Keywords:

References

1. Torres AE, Lim HW. Photobiomodulation for the management of hair loss. Photodermatol. Photoimmunol. Photomed. 37(2), 91–98 (2021).
MedlineGoogle Scholar
2. Kalhori KAM, Vahdatinia F, Jamalpour MR et al. Photobiomodulation in oral medicine. Photobiomodul. Photomed. Laser Surg. 37(12), 837–861 (2019).
MedlineGoogle Scholar
3. Zadik Y, Arany PR, Fregnani ER et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support. Care Cancer 27(10), 3969–3983 (2019).
MedlineGoogle Scholar
4. Anders JJ, Lanzafame RJ, Arany PR. Low-level light/laser therapy versus photobiomodulation therapy. Photomed. Laser Surg. 33(4), 183–184 (2015).
MedlineGoogle Scholar
5. Courtois E, Bouleftour W, Guy JB et al. Mechanisms of photobiomodulation (PBM) focused on oral mucositis prevention and treatment: a scoping review. BMC Oral Health 21(1), 220 (2021).
MedlineGoogle Scholar
6. Cronshaw M, Parker S, Anagnostaki E, Mylona V, Lynch E, Grootveld M. Photobiomodulation and oral mucositis: a systematic review. Dent. J. (Basel) 8(3), 87 (2020).
Google Scholar
7. Bensadoun RJ. Photobiomodulation or low-level laser therapy in the management of cancer therapy-induced mucositis, dermatitis and lymphedema. Curr. Opin. Oncol. 30(4), 226–232 (2018).
MedlineGoogle Scholar
8. Adnan A, Yaroslavsky AN, Carroll JD et al. The path to an evidence-based treatment protocol for extraoral photobiomodulation therapy for the prevention of oral mucositis. Front. Oral Health 2, 689386 (2021).
MedlineGoogle Scholar
9. Elting LS, Chang YC. Costs of oral complications of cancer therapies: estimates and a blueprint for future study. J. Natl Cancer Inst. Monogr. 2019(53), lgz010 (2019).
MedlineGoogle Scholar
10. Salehpour F, Mahmoudi J, Kamari F, Sadigh-Eteghad S, Rasta SH, Hamblin MR. Brain photobiomodulation therapy: a narrative review. Mol. Neurobiol. 55(8), 6601–6636 (2018).
Medline CASGoogle Scholar
11. Huang YY, Nagata K, Tedford CE, McCarthy T, Hamblin MR. Low-level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro. J. Biophotonics 6(10), 829–838 (2013).
Medline CASGoogle Scholar
12. Naeser MA, Saltmarche A, Krengel MH, Hamblin MR, Knight JA. Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed. Laser Surg. 29(5), 351–358 (2011).
MedlineGoogle Scholar
13. Rojas JC, Bruchey AK, Gonzalez-Lima F. Low-level light therapy improves cortical metabolic capacity and memory retention. J. Alzheimers Dis. 32(3), 741–752 (2012).
MedlineGoogle Scholar
14. Hill BC. Modeling the sequence of electron transfer reactions in the single turnover of reduced, mammalian cytochrome c oxidase with oxygen. J. Biol. Chem. 269(4), 2419–2425 (1994).
Medline CASGoogle Scholar
15. Karu TI, Kolyakov SF. Exact action spectra for cellular responses relevant to phototherapy. Photomed. Laser Surg. 23(4), 355–361 (2005).
Medline CASGoogle Scholar
16. Santana-Blank L, Rodriguez-Santana E, Santana-Rodriguez K. Theoretic, experimental, clinical bases of the water oscillator hypothesis in near-infrared photobiomodulation. Photomed. Laser Surg. 28(Suppl. 1), S41–S52 (2010).
Medline CASGoogle Scholar
17. Hamblin MR, Hamblin MR, Waynant RW, Anders J. The role of nitric oxide in low level light therapy. Mechanisms for Low-Light Therapy III doi: 10.1117/12.764918 (2008) (Epub ahead of print).
Google Scholar
18. Karu TI, Karu TI, Lubart R. Mechanisms of low-power laser light action on cellular level. Effects of Low-Power Light on Biological Systems V doi: 10.1117/12.405918 (2000) (Epub ahead of print).
Google Scholar
19. De Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J. Sel. Top. Quantum Electron. 22(3), 7000417 (2016).
MedlineGoogle Scholar
20. Gao X, Xing D. Molecular mechanisms of cell proliferation induced by low power laser irradiation. J. Biomed. Sci. 16, 4 (2009).
MedlineGoogle Scholar
21. Zhang D, Spielmann A, Wang L et al. Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2. Physiol. Res. 61(1), 113–124 (2012).
Medline CASGoogle Scholar
22. Feng Q. Temperature sensing by thermal TRP channels: thermodynamic basis and molecular insights. Curr. Top. Membr. 74, 19–50 (2014).
Medline CASGoogle Scholar
23. Nishida M, Hara Y, Yoshida T, Inoue R, Mori Y. TRP channels: molecular diversity and physiological function. Microcirculation 13(7), 535–550 (2006).
Medline CASGoogle Scholar
24. Albert ES, Bec JM, Desmadryl G et al. TRPV4 channels mediate the infrared laser-evoked response in sensory neurons. J. Neurophysiol. 107(12), 3227–3234 (2012).
Medline CASGoogle Scholar
25. Lopes NN, Plapler H, Lalla RV et al. Effects of low-level laser therapy on collagen expression and neutrophil infiltrate in 5-fluorouracil-induced oral mucositis in hamsters. Lasers Surg. Med. 42(6), 546–552 (2010).
MedlineGoogle Scholar
26. Jadaud E, Bensadoun R. Low-level laser therapy: a standard of supportive care for cancer therapy-induced oral mucositis in head and neck cancer patients? Laser Ther. 21(4), 297–303 (2012).
Medline CASGoogle Scholar
27. Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 9(9), e107418 (2014).
MedlineGoogle Scholar
28. Hanna R, Dalvi S, Benedicenti S et al. Photobiomodulation therapy in oral mucositis and potentially malignant oral lesions: a therapy towards the future. Cancers (Basel) 12(7), 1949 (2020).
CASGoogle Scholar
29. Oton-Leite AF, Correa De Castro AC, Morais MO, Pinezi JC, Leles CR, Mendonca EF. Effect of intraoral low-level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy. Head Neck 34(3), 398–404 (2012).
MedlineGoogle Scholar
30. El Mobadder M, Farhat F, El Mobadder W, Nammour S. Photobiomodulation therapy in the treatment of oral mucositis, dysphagia, oral dryness, taste alteration, and burning mouth sensation due to cancer therapy: a case series. Int. J. Environ. Res. Public Health 16(22), 4505 (2019).
Google Scholar
31. OraMaxRX. OraMaxRX (2021). www.oramaxrx.com/oramaxrx-laser
Google Scholar
32. Martins AFL, Nogueira TE, Morais MO et al. Cost–effectiveness randomized clinical trial on the effect of photobiomodulation therapy for prevention of radiotherapy-induced severe oral mucositis in a Brazilian cancer hospital setting. Support. Care Cancer 29(3), 1245–1256 (2021).
MedlineGoogle Scholar
33. Campos TM, Do Prado Tavares Silva CA, Sobral APT et al. Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis. Support. Care Cancer 28(12), 5649–5659 (2020).
MedlineGoogle Scholar
34. Hennessy M, Hamblin MR. Photobiomodulation and the brain: a new paradigm. J. Opt. 19(1), 013003 (2017).
MedlineGoogle Scholar
35. Pandeshwar P, Roa MD, Das R, Shastry SP, Kaul R, Srinivasreddy MB. Photobiomodulation in oral medicine: a review. J. Investig. Clin. Dent. 7(2), 114–126 (2016).
MedlineGoogle Scholar

Vol. 17, No. 9

Metrics

Downloaded 108 times

History

Received 28 May 2022

Accepted 7 June 2022

Published online 22 June 2022

Published in print September 2022

Information

Keywords

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants, or patents received or pending or royalties.

No writing assistance was utilized in the production of this manuscript.

PDF download